Brief: Visen Pharmaceuticals Says NMPA Approves Lonapegsomatropin (Skytrofa) For Injection26/01/2026 16:58
Brief: Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 Million20/03/2025 17:28
Last trade - 00:00Last trade - 00:00Last trade - 00:00